Edgestream Partners L.P. bought a new stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 312,973 shares of the company’s stock, valued at approximately $4,710,000.
Several other hedge funds have also made changes to their positions in the stock. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Avantor in the third quarter valued at $26,000. Elevation Wealth Partners LLC increased its holdings in shares of Avantor by 72.3% in the 3rd quarter. Elevation Wealth Partners LLC now owns 2,803 shares of the company’s stock worth $42,000 after acquiring an additional 1,176 shares during the period. Root Financial Partners LLC bought a new stake in Avantor in the 3rd quarter valued at about $57,000. Nisa Investment Advisors LLC lifted its position in Avantor by 40.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 4,938 shares of the company’s stock valued at $74,000 after purchasing an additional 1,431 shares during the last quarter. Finally, IFP Advisors Inc raised its holdings in shares of Avantor by 901.4% during the second quarter. IFP Advisors Inc now owns 5,858 shares of the company’s stock valued at $58,000 after buying an additional 5,273 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.
Avantor Stock Performance
Shares of AVTR stock opened at $15.11 on Friday. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $17.45. The stock’s 50-day moving average is $15.72 and its two-hundred day moving average is $11.50. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.89 and a quick ratio of 1.27. The firm has a market cap of $10.24 billion, a P/E ratio of 30.21, a PEG ratio of 6.96 and a beta of 0.95.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings results on Wednesday, October 28th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a net margin of 5.08% and a return on equity of 9.79%. Avantor’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.22 EPS. Analysts predict that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.
Key Avantor News
These are some of the AVTR news items that stood out recently:
- Positive Sentiment: Zacks raised its FY2026 EPS estimate to $0.81 from $0.80, FY2027 to $0.86 from $0.85, and FY2028 to $0.93 from $0.92. It also lifted estimates for Q1–Q3 2027 and Q2 2028 by $0.01 per share each. The upward revisions suggest a slightly improved earnings outlook. MarketBeat Avantor coverage
- Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $0.21 from $0.22 and Q4 2027 to $0.21 from $0.23, indicating some weaker expectations for those quarters. MarketBeat Avantor coverage
Analysts Set New Price Targets
A number of brokerages recently issued reports on AVTR. Robert W. Baird increased their target price on shares of Avantor from $17.00 to $18.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. Stifel Nicolaus raised their price objective on shares of Avantor from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Thursday, October 29th. Royal Bank Of Canada boosted their target price on Avantor from $14.00 to $17.00 and gave the stock a “sector perform” rating in a report on Wednesday, October 28th. Jefferies Financial Group upgraded Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price target on the stock in a research report on Wednesday, July 29th. Finally, TD Cowen lifted their price target on Avantor from $15.00 to $17.00 and gave the stock a “hold” rating in a research note on Tuesday, October 13th. Two research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Avantor has a consensus rating of “Hold” and a consensus price target of $14.77.
Get Our Latest Stock Analysis on Avantor
Avantor Profile
Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.
Read More
- Five stocks we like better than Avantor
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
